查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2050459

微生物附著量檢測市場：按產品、檢測類型、應用、最終用戶和地區分類

Bioburden Testing Market, By Product, By Test Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年，微生物附著量檢測市場規模將達到 15.3 億美元，到 2033 年將達到 29.1 億美元。預計從 2026 年到 2033 年，該市場將以 9.6% 的複合年成長率成長。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 15.3億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 9.60% 2033年市場規模預測： 29.1億美元

微生物附著量檢測是指對產品、原料或表面上存在的微生物進行檢測和定量。微生物附著量檢測對於藥品和醫療保健產品的品管至關重要，它能確保生產過程中使用的材料和設備符合相應的衛生標準。此外，它在維持無菌狀態和防止無菌醫療設備、設備和成品受到污染方面也發揮關鍵作用。由於醫療設備檢測的嚴格法規、契約製造組織 (CMO) 的日益普及以及藥品生產外包的增加，微生物附著量負荷檢測市場正在蓬勃發展。維持無菌狀態和防止微生物滋生至關重要，因為醫療設備和藥品直接與患者接觸。微生物附著量檢測提供了一種品管工具，用於驗證滅菌製程的有效性，並檢測在生產或運輸過程中可能引入的污染物。這些檢測結果有助於確定合適的儲存期限，並有助於調查未來產品批次可能存在的問題。

市場動態

全球微生物附著量檢測市場主要受製藥和醫療設備生產中嚴格的微生物附著量檢測監管要求所驅動。美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構要求在非無菌產品的各個階段進行微生物附著量檢測，以確保其安全性和有效性。製藥和醫療設備產業的成長也推動了對微生物附著量檢測的需求。然而，微生物附著量檢測設備和服務的高昂成本限制了該市場的成長。快速、自動化微生物附著量檢測解決方案的出現帶來了巨大的商機，因為它能夠更快地獲得檢測結果並提高處理能力。未來幾年，在生產過程中實施微生物附著量檢測的連續監測系統也將帶來更多機會。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
  • 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數對全球微生物附著量檢測市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
  • 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球微生物附著量檢測市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場概覽

  • 報告說明
  • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章：微生物附著量檢測市場：依產品分類，2021-2033年

  • 消耗品
  • 培養基
  • 試劑和試劑盒
  • 裝置
  • 自動化微生物鑑定系統
  • PCR設備

第5章：微生物附著量檢測市場：依檢測類型分類，2021-2033年

  • 需氣菌計數試驗
  • 厭氧菌計數試驗
  • 真菌和黴菌計數測量
  • 孢子計數測量

第6章：微生物附著量檢測市場：依應用領域分類，2021-2033年

  • 原料測試
  • 醫療設備測試
  • 製造過程中的材料測試
  • 滅菌驗證測試
  • 設備清潔驗證

第7章：微生物附著量檢測市場：依最終用途分類，2021-2033年

  • 製藥和生物技術公司
  • 醫療設備製造商
  • 契約製造組織
  • 食品、飲料和農產品製造商
  • 微生物檢測實驗室

第8章：微生物附著量檢測市場：依地區分類，2021-2033年

  • 按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東和非洲
    • GCC
    • 以色列
    • 其他中東國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷

第9章：公司概況：微生物附著量檢測市場

  • Charles River Laboratories International, Inc.
    • 公司簡介
    • 產品和服務組合
    • 財務業績
    • 近期趨勢和最新信息
    • 戰略概覽
  • SGS SA
  • Merck KGaA
  • Becton
  • Dickinson and Company
  • Wuxi Apptec
  • North American Science Associates Inc.
  • Nelson Laboratories, LLC
  • Biomerieux SA
  • Thermo Fisher Scientific
  • Pacific Biolabs

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI6605

Bioburden Testing Market is estimated to be valued at USD 1.53 Bn in 2026 and is expected to reach USD 2.91 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1.53 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.60% 2033 Value Projection: USD 2.91 Bn

Bioburden testing refers to the detection and quantification of microorganisms present in or on a product, raw material, or surface. Bioburden testing helps monitor the quality of pharmaceutical and healthcare products by ensuring materials and equipment used in production meet appropriate hygienic standards. It plays a key role in maintaining sterility and preventing contamination of sterile devices, equipment, and finished products. The bioburden testing market is growing due to stringent regulations mandating testing of medical devices, rising penetration of contract manufacturing organizations, and increasing outsourcing of pharmaceutical manufacturing. As medical devices and pharmaceuticals are intended to interact directly with patients, maintaining sterility and preventing microbial growth are critical. Bioburden testing provides quality control measures to validate sterilization processes and detect any contaminants that may have been introduced during manufacturing or shipping. The results of these tests help determine appropriate shelf life and assist in investigations should any issues arise with a product batch in the future.

Market Dynamics

The global bioburden testing market is driven by stringent regulatory mandates for the testing of bioburden in pharmaceutical and medical device manufacturing. Regulatory agencies like the Food and Drug Administration. FDA and European Medicines Agency EMA require bioburden testing at various stages to ensure the safety and efficacy of non-sterile products. The growth in pharmaceutical and medical device industries has also fueled the demand for bioburden testing. However, the high costs associated with bioburden testing equipment and services limit the growth of this market. The emergence of rapid automated bioburden testing solutions presents lucrative opportunities, as they enable faster results and higher throughput. The adoption of continuous monitoring systems for bioburden testing during manufacturing further offers opportunities in the coming years.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global bioburden testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Charles River Laboratories, Merck KGaA, SGS, WuXi AppTec, and Becton, Dickinson and Company ,North American Science Associates Inc. , Nelson Laboratories LLC , Biomerieux SA ,Thermo Fisher ScientifiC and Pacific Biolabs.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global bioburden testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

  • Bioburden Testing Market,By Product (Revenue, USD Bn, 2021 - 2033)
  • Consumables
  • Culture Media
  • Reagents and Kits
  • Instruments
  • Automated Microbial Identification Systems
  • PCR Instruments
  • Bioburden Testing Market, By Test Type (Revenue, USD Bn, 2021 - 2033)
  • Aerobic Count Testing
  • Anaerobic Count Testing
  • Fungi/Mold Count Testing
  • Spore Count Testing
  • Bioburden Testing Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Raw Material Testing
  • Medical Device Testing
  • In-Process Material Testing
  • Sterilization Validation Testing
  • Equipment Cleaning Validation
  • Bioburden Testing Market, By End Use (Revenue, USD Bn, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Manufacturing Organizations
  • Manufacturers of Food & Beverage and Agricultural Products
  • Microbial Testing Laboratories
  • Bioburden Testing Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top Companies in the Bioburden Testing Market
  • Charles River Laboratories International Inc.
  • SGS SA
  • Merck KGaA
  • Becton
  • Dickinson and Company
  • Wuxi Apptec
  • North American Science Associates Inc.
  • Nelson Laboratories LLC
  • Biomerieux SA,
  • Thermo Fisher Scientific
  • Pacific Biolabs.

Table of Content

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
    • Bioburden Testing Market, By Product
    • Bioburden Testing Market, By Test Type
    • Bioburden Testing Market, By Application
    • Bioburden Testing Market, By End Use
    • Bioburden Testing Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Bioburden Testing Market, By Product, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Consumables, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Culture Media, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Reagents and Kits, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Instruments, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Automated Microbial Identification System, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • PCR Instruments, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Bioburden Testing Market, By Test Type, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Aerobic Count Testing, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Anaerobic Count Testing, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Fungi/Mold Count Testing, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Spore Count Testing, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Bioburden Testing Market, By Application, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Raw Material Testing, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Medical Device Testing, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • In-process Material Testing, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Sterilization Validation Testing, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecas and Y-o-Y Growth t, 2021 - 2033, (USD Bn)
  • Equipment Cleaning Validation, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Bioburden Testing Market, By End Use, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies , 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Medical Device Manufacturers , 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth 2021 - 2033, (USD Bn)
  • Contract Manufacturing Organizations , 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Manufacturers Of Food & Beverage And Agricultural Products , 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Microbial Testing Laboratories, 2021 - 2033 (USD Bn)
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Bioburden Testing Market, By Region, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2021 - 2033, (USD Bn)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • By Region
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • North America
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By End Use, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By End Use, 2021 - 2033, (USD Bn)
    • Market Size and Forecas and Y-o-Y Growth t, By Country, 2021 - 2033, (USD Bn)
      • U.K
      • German
      • Italy
      • France
      • Spain
      • Russia
      • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By End Use, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Asean
      • Rest Of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, By Product and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End Use and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest Of Middle East
  • Latin America
    • Introduction
    • Market Size and Forecast and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By End Use, 2021 - 2033, (USD Bn)
    • Market Size and Forecast and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina

9. Company Profiles - Bioburden Testing Market

  • Charles River Laboratories International, Inc.
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • SGS SA
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Merck KGaA
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Becton
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Dickinson and Company
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Wuxi Apptec
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • North American Science Associates Inc.
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Nelson Laboratories, LLC
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Biomerieux SA
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Thermo Fisher Scientific
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Pacific Biolabs
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact